​

Funding Round

Venture Round - Exicure

Venture Round - Exicure

Investment Firm

Overview

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

Announced Date

Sep 27, 2017

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorDavid R. Walt
Participant InvestorEric Lefkofsky
Participant InvestorTempus
Participant InvestorBill Gates
Participant InvestorCraig Mundie

Round Details and Background

Exicure raised $20000000 on 2017-09-27 in Venture Round

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 17, 2014
Series C - Exicure
4-13.6M
Dec 01, 2009
Series A - Exicure
-2.5M
Jul 31, 2013
Series B - Exicure
1-undefined
Dec 21, 2011
Series B - Exicure
5-5.4M

Recent Activity

There is no recent news or activity for this profile.